Home / Inspections / 1297650

FDA Inspection 1297650 — Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany

Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany — FEI 2211084

The FDA completed an inspection of Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany on December 8, 2025 in Whippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 8, 2025
Fiscal Year
2026
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Whippany, NJ (United States)

Facility

Other inspections at this facility

  • 1197680 (NAI Fri Feb 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1116333 (VAI Fri Dec 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1055544 (VAI Wed May 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1027562 (NAI Thu Aug 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008344 (VAI Mon Mar 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources